IC del 95%, -1,2% a -0,2%)
What the Research Shows on Semaglutide and Tirzepatide The relationship between GLP-1 medications and skin laxity is well-documented in the aesthetic-medicine literature, which increasingly frames GLP-1-associated skin changes as a legitimate concern requiring proactive management
Only 13 states provided coverage as of January 2026, down from 16 states in 2025, likely reflecting the significant costs of coverage and recent state budget challenges and federal funding cuts
Its about creating specific periods for eating and fasting, which can bring several health benefits
Nevertheless, caution is warranted in individuals with diabetes or those at risk of hypoglycaemia, particularly if they are also taking insulin or a sulfonylurea